Endocrine consequences of treatment with the new androgen receptor axis-targeted agents for advanced prostate cancer
Crossref DOI link: https://doi.org/10.1007/s42000-020-00251-5
Published Online: 2020-11-02
Published Print: 2021-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pyrgidis, Nikolaos
Vakalopoulos, Ioannis
Sountoulides, Petros https://orcid.org/0000-0003-2671-571X
Text and Data Mining valid from 2020-11-02
Version of Record valid from 2020-11-02
Article History
Received: 4 June 2020
Accepted: 8 October 2020
First Online: 2 November 2020
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.